VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism
Frontiers in Cardiovascular Medicine · 24.12.2024 · 11
DOI: 10.3389/fcvm.2024.1457157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 24.12.2024. Verfasst von Zhenhang Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Percutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. However, there are few reports of VA-ECOM-assisted PMT in the treatment of high-risk PE. The purpose of this study is to summarize the data of 11 patients with high-risk PE treated with VA-ECMO assisted PMT, and propose feasible treatment methods for such patients.
Methods
This multicenter retrospective study included patients with acute high-risk PE who were treated with VA-ECMO-assisted PMT from January 2021 to June 2024. The analysis focused on the right/left ventricle ratio, biomarkers, and pulmonary artery pressure before and after the VA-ECMO-assisted PMT treatment.
Results
All 11 high-risk PE patients suffered cardiac arrest before treatment, computered tomograhy pulmonary angiography (CTPA) confirmed the diagnosis of PE, and all patients received VA-ECMO-assisted PMT therapy. The median age of the 11 patients was 54 years (range 18–72), the median duration of ECMO was 4.48 days (range 1.04–18.02), and the mean hospitalization time was 21 days (range 14–112). All patients received percutaneous thrombectomy, achieving a 100% technical success rate. The mortality rate was 27.3% during the 90-day follow-up. The 12-month mortality rate was 36.4%.
Conclusion
VA-ECMO-assisted PMT technology can rapidly improve pulmonary hemodynamics while maintaining stable blood flow, thereby reducing in-hospital mortality in high-risk patients with pulmonary embolism complicated by cardiac arrest.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Hunan Province Thrombotic Disease Prevention and Treatment Clinical Medical Research Center, Hengyang, Hunan, China.
- Hunan Provincial Key Clinical Specialty, Hengyang, Hunan, China.
- Department of Critical Care Medicine, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Department of Vascular Surgery, Zhongshan Hospital Xiamen University, Xiamen, Fujian, China.
Zitieren
APA
Zhou, Z., Zhong, Y., Hu, J., Wu, Z., Zou, L., Deng, Z., Bi, G., Shen, X., Dai, X., Huang, Z., Xiong, G., Xu, Y., & Deng, L. (2024). VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1457157
Vancouver
Zhou Z, Zhong Y, Hu J, Wu Z, Zou L, Deng Z, et al. VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1457157
BibTeX
@article{Zhou2024,
author = {Zhou, Zhenhang and Zhong, Yaoyang and Hu, Jianbo and Wu, Zhonghua and Zou, Liping and Deng, Zhihe and Bi, Guoshan and Shen, Xin and Dai, Xianpeng and Huang, Zhijia and Xiong, Guozuo and Xu, Yiming and Deng, Liming},
title = {VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1457157}
}
EUVIMED